Geisinger Medical Oncology-Lewisburg — Lewisburg, Pennsylvania

Geisinger Medical Oncology-Lewisburg is a clinical research site located in Lewisburg, Pennsylvania, United States 17837.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Geisinger Medical Oncology-Lewisburg has participated in 204 clinical trials with 137 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lewisburg

Browse all research sites in Pennsylvania · View every site in Lewisburg

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Geisinger Medical Oncology-Lewisburg?

Geisinger Medical Oncology-Lewisburg has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Geisinger Medical Oncology-Lewisburg conducted?

Geisinger Medical Oncology-Lewisburg has 204 clinical trials on record, with 137 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Geisinger Medical Oncology-Lewisburg accredited by Crixeo Clinical Trials?

Geisinger Medical Oncology-Lewisburg has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Geisinger Medical Oncology-Lewisburg?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.